Gene · 190
Papers3,637
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 3,637
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Report: central diabetes insipidus and schwannoma in a male with X-linked congenital adrenal hypoplasia. | BMC Endocr Disord | 2020 | 32460754 | PubTator, text mining | PubMed |
| Network Pharmacology-Based Prediction of Active Ingredients and Potential Targets of ShengDiHuang Decoction for Treatment of Dysfunctional Uterine Bleeding. | Evid Based Complement Alternat Med | 2020 | 32454870 | PubTator, text mining | PubMed |
| NR1D2 Accelerates Hepatocellular Carcinoma Progression by Driving the Epithelial-to-Mesenchymal Transition. | Onco Targets Ther | 2020 | 32440156 | PubTator, text mining | PubMed |
| Integrated Structural Modeling of Full-Length LRH-1 Reveals Inter-domain Interactions Contribute to Receptor Structure and Function. | Structure | 2020 | 32433991 | Swiss-Prot, curated | PubMed |
| Efficient N-Glycosylation of the Heavy Chain Tailpiece Promotes the Formation of Plant-Produced Dimeric IgA. | Front Chem | 2020 | 32426328 | PubTator, text mining | PubMed |
| Conversion between porcine naïve-like and primed ESCs and specific pluripotency marker identification. | In Vitro Cell Dev Biol Anim | 2020 | 32424450 | PubTator, text mining | PubMed |
| ER-luminal [Ca2+] regulation of InsP3 receptor gating mediated by an ER-luminal peripheral Ca2+-binding protein. | Elife | 2020 | 32420875 | PubTator, text mining | PubMed |
| Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma. | Nat Commun | 2020 | 32415069 | PubTator, text mining | PubMed |
| Spironolactone and XPB: An Old Drug with a New Molecular Target. | Biomolecules | 2020 | 32414008 | PubTator, text mining | PubMed |
| Hair Regeneration Potential of Human Dermal Sheath Cells Cultured Under Physiological Oxygen. | Tissue Eng Part A | 2020 | 32408803 | PubTator, text mining | PubMed |
| PPARG Drives Molecular Networks as an Inhibitor for the Pathologic Development and Progression of Lung Adenocarcinoma. | PPAR Res | 2020 | 32395124 | PubTator, text mining | PubMed |
| The Dysregulated Pharmacology of Clinically Relevant ESR1 Mutants is Normalized by Ligand-activated WT Receptor. | Mol Cancer Ther | 2020 | 32381587 | PubTator, text mining | PubMed |
| Hypogonadotropic hypogonadism due to variants in RAB3GAP2: expanding the phenotypic and genotypic spectrum of Martsolf syndrome. | Cold Spring Harb Mol Case Stud | 2020 | 32376645 | PubTator, text mining | PubMed |
| PPAR Beta/Delta and the Hallmarks of Cancer. | Cells | 2020 | 32375405 | PubTator, text mining | PubMed |
| Evaluating the Role of the Steroid and Xenobiotic Receptor (SXR/PXR) in PCB-153 Metabolism and Protection against Associated Adverse Effects during Perinatal and Chronic Exposure in Mice. | Environ Health Perspect | 2020 | 32352317 | PubTator, text mining | PubMed |
| Male Hypogonadism and Disorders of Sex Development. | Front Endocrinol (Lausanne) | 2020 | 32351452 | PubTator, text mining | PubMed |
| Recent progress on the role and molecular mechanism of chicken ovalbumin upstream promoter-transcription factor II in cancer. | J Int Med Res | 2020 | 32338091 | PubTator, text mining | PubMed |
| Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation. | Mol Oncol | 2020 | 32333502 | PubTator, text mining | PubMed |
| Filamin B extensively regulates transcription and alternative splicing, and is associated with apoptosis in HeLa cells. | Oncol Rep | 2020 | 32323860 | PubTator, text mining | PubMed |
| Epigenetic control of the EWS‑FLI1 promoter in Ewing's sarcoma. | Oncol Rep | 2020 | 32323788 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/190/papers?page=57